Metabolic syndrome: a closer look at the growing epidemic and its associated pathologiesSadhbh O’Neill, Lorraine O’Driscoll|Obesity Reviews|2014Cited by 1.6k
Three-dimensional cell culture: the missing link in drug discoverySusan Breslin, Lorraine O’Driscoll|Drug Discovery Today|2012Cited by 1.3k
Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesiclesVanesa G. Martínez, Lorraine O’Driscoll|OncoImmunology|2017Cited by 136
miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancerClaire Corcoran, Lorraine O’Driscoll|Molecular Cancer|2014Cited by 77
Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2‐positive breast cancerVanesa G. Martínez, Lorraine O’Driscoll|International Journal of Cancer|2017Cited by 38